343VP Duchenne muscular dystrophy: the critical role of pulmonary infection in survival outcomes

L. Wahlgren,A. Kroksmark,M. Tulinius,K. Sofou
DOI: https://doi.org/10.1016/j.nmd.2024.07.683
IF: 3.538
2024-10-05
Neuromuscular Disorders
Abstract:The progressive decline of pulmonary function is widely known as a cause of early mortality in Duchenne muscular dystrophy (DMD). Advances in respiratory care including early identification of hypoventilation and introduction of respiratory aids are expected to increase the life expectancy in these patients. The aim of this study was to explore the effect of respiratory related comorbidities on survival outcomes in DMD. This was a cause-of-death, retrospective study of all male patients living in Sweden with a confirmed diagnosis of DMD, born since 1970 and deceased by 2019. Patients were identified through multiple data sources, including pathology laboratories, national registries and by contacting the national network of clinicians working with neuromuscular diseases in Sweden. A total of 129 patients were identified. More than 2 out of 3 patients had suffered at least one episode of pneumonia, the first episode of pneumonia occurring before adolescence in 24%. Major clinical events following acute pulmonary infection were acute tracheostomy, start or worsening of hypoventilation, unplanned hospitalization and death. Median (IQR) time from first pneumonia to death was 6.8 (1.9-10.3) years. There was a strong correlation between acute pulmonary infection and hypoventilation. Acute pulmonary infection has a considerable impact on respiratory-related, early death in DMD. Regular follow-ups to promptly recognize subclinical hypoventilation and the existence of respiratory-specific protocols in the care of patients with DMD might help improve these outcomes.
neurosciences,clinical neurology
What problem does this paper attempt to address?